Suppr超能文献

Crohn's Disease Discovery to Modern Treatment: A Gastroenterology Fellow's Experience at Mount Sinai With the Crohn's & Colitis Foundation Visiting Fellowship Program.

作者信息

Pattison Robert James, Djalal Arafa

机构信息

Department of Gastroenterology, Straub Medical Center, Honolulu, HI.

Mt. Sinai Medical Center, New York, NY.

出版信息

ACG Case Rep J. 2024 Oct 10;11(10):e01533. doi: 10.14309/crj.0000000000001533. eCollection 2024 Oct.

DOI:10.14309/crj.0000000000001533
PMID:39391803
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11466137/
Abstract
摘要

相似文献

1
Crohn's Disease Discovery to Modern Treatment: A Gastroenterology Fellow's Experience at Mount Sinai With the Crohn's & Colitis Foundation Visiting Fellowship Program.克罗恩病从发现到现代治疗：一名胃肠病学研究员在西奈山参加克罗恩病和结肠炎基金会访问学者项目的经历
ACG Case Rep J. 2024 Oct 10;11(10):e01533. doi: 10.14309/crj.0000000000001533. eCollection 2024 Oct.
2
Training Pearl: Welcome to the CC360 Fellow's Corner.培训小贴士：欢迎来到CC360研究员专区。
Crohns Colitis 360. 2023 Oct 27;5(4):otad060. doi: 10.1093/crocol/otad060. eCollection 2023 Oct.
3
Crohn's & Colitis 360 Editorial Fellowship: The Inaugural Fellow's Insights.《克罗恩病与结肠炎360编辑奖学金：首届奖学金获得者的见解》
Crohns Colitis 360. 2024 Jan 31;6(1):otae002. doi: 10.1093/crocol/otae002. eCollection 2024 Jan.
4
To make a difference: the founding of the Crohn's and Colitis Foundation of America.创造改变：美国克罗恩病和结肠炎基金会的创立
Mt Sinai J Med. 2001 Mar;68(2):113-6.
5
Crohn's disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure.克罗恩病、不确定性结肠炎与回肠储袋肛管吻合术：结局与失败模式
Dis Colon Rectum. 2005 Aug;48(8):1542-9. doi: 10.1007/s10350-005-0059-z.
6
Increasing Exposure to Inflammatory Bowel Diseases Education in Gastroenterology Fellowship: The Pilot IBD 101 Experience.在胃肠病学 fellowship 中增加对炎症性肠病的教育：IBD 101 试点经验。
Inflamm Bowel Dis. 2025 Mar 3;31(3):746-750. doi: 10.1093/ibd/izad311.
7
Long-term outcome of colectomy and ileorectal anastomosis for Crohn's colitis.克罗恩病性结肠炎结肠切除回肠直肠吻合术的长期疗效。
Dis Colon Rectum. 2011 Nov;54(11):1347-54. doi: 10.1097/DCR.0b013e31822c9b2d.
8
A national survey on the patterns of treatment of inflammatory bowel disease in Canada.一项关于加拿大炎症性肠病治疗模式的全国性调查。
BMC Gastroenterol. 2003 Jun 5;3:10. doi: 10.1186/1471-230X-3-10.
9
A SPECIAL MEETING REVIEW EDITION: Highlights in Inflammatory Bowel Disease From the 14th Congress of ECCO: A Review of Selected Presentations From the 14th Congress of the European Crohn's and Colitis Organisation (ECCO) • March 6-9, 2019 • Copenhagen, Denmark• VARSITY: A Double-Blind, Double-Dummy, Randomized Controlled Trial of Vedolizumab Versus Adalimumab in Patients With Active Ulcerative Colitis• Analyses of Data From the VISIBLE 1 and 2 Trials: Vedolizumab in Patients With Ulcerative Colitis or Crohn's Disease• Improved Endoscopic Outcomes and Mucosal Healing of Upadacitinib as an Induction Therapy in Adults With Moderately to Severely Active Ulcerative Colitis: Data From the U-ACHIEVE Study• Long-Term Safety of Vedolizumab in Ulcerative Colitis and Crohn's Disease: Final Results From the GEMINI LTS Study• Pediatric Crohn's Disease Adalimumab Level-Based Optimization Treatment (PAILOT) Randomized Controlled Trial• Maintenance Treatment With Mirikizumab, a P19-Directed IL-23 Antibody: 52-Week Results in Patients With Moderately to Severely Active Ulcerative Colitis• Real-World Effectiveness and Safety of Vedolizumab and Anti-TNF Therapy in Biologic-Naive Patients With Ulcerative Colitis or Crohn's Disease: Results From the EVOLVE Study• A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of a Targeted-Release Oral Cyclosporine Formulation in the Treatment of Mild to Moderate Ulcerative Colitis: Efficacy Results• Real-World Analyses of Patients With IBD Treated With Vedolizumab Professor of MedicineDivision of Gastroenterology and HepatologyMayo ClinicRochester, Minnesota.特别会议回顾版：欧洲克罗恩病和结肠炎组织（ECCO）第14届大会炎症性肠病亮点：对第14届欧洲克罗恩病和结肠炎组织（ECCO）大会部分演讲的回顾 • 2019年3月6 - 9日 • 丹麦哥本哈根• VARSITY：维多珠单抗与阿达木单抗治疗活动性溃疡性结肠炎患者的双盲、双模拟、随机对照试验• 来自VISIBLE 1和2试验的数据分析：维多珠单抗治疗溃疡性结肠炎或克罗恩病患者• 乌帕替尼作为中度至重度活动性溃疡性结肠炎成人诱导治疗的内镜结果改善和黏膜愈合：U - ACHIEVE研究数据• 维多珠单抗治疗溃疡性结肠炎和克罗恩病的长期安全性：GEMINI LTS研究最终结果• 儿童克罗恩病阿达木单抗基于水平的优化治疗（PAILOT）随机对照试验• 抗P19导向的IL - 23抗体mirikizumab维持治疗：中度至重度活动性溃疡性结肠炎患者52周结果• 维多珠单抗和抗TNF治疗在初治溃疡性结肠炎或克罗恩病患者中的真实世界有效性和安全性：EVOLVE研究结果• 靶向释放口服环孢素制剂治疗轻至中度溃疡性结肠炎的随机、多中心、双盲、安慰剂对照研究：疗效结果• 接受维多珠单抗治疗的炎症性肠病患者的真实世界分析 医学教授 胃肠病学和肝病科 梅奥诊所 明尼苏达州罗切斯特
Gastroenterol Hepatol (N Y). 2019 May;15(5 Suppl 2):1-24.
10
A history of immunosuppressive drugs in the treatment of inflammatory bowel disease: origins at The Mount Sinai Hospital.免疫抑制药物治疗炎症性肠病的历史：起源于西奈山医院。
Mt Sinai J Med. 2000 May;67(3):214-26.

本文引用的文献

1
Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.比较生物疗法在诱导瘘管性克罗恩病缓解和应答中的疗效：系统评价和随机对照试验的网络荟萃分析。
Inflamm Bowel Dis. 2023 Mar 1;29(3):367-375. doi: 10.1093/ibd/izac103.
2
Net Remission Rates with Biologic Treatment in Crohn's Disease: A Reappraisal of the Clinical Trial Data.生物治疗对克罗恩病的净缓解率：对临床试验数据的再评估。
Clin Gastroenterol Hepatol. 2023 May;21(5):1348-1350. doi: 10.1016/j.cgh.2022.02.044. Epub 2022 Mar 1.
3
Efficacy and safety of simultaneous treatment with two biologic medications in refractory Crohn's disease.两种生物制剂联合治疗难治性克罗恩病的疗效和安全性。
Aliment Pharmacol Ther. 2020 Jun;51(11):1031-1038. doi: 10.1111/apt.15719. Epub 2020 Apr 24.
4
The Whys and Hows of Fourth-Year Inflammatory Bowel Disease Fellowships.关于炎症性肠病四年级研究员培训的缘由与方式
Dig Dis Sci. 2017 May;62(5):1116-1118. doi: 10.1007/s10620-017-4555-5.
5
Regional ileitis: a pathologic and clinical entity. 1932.局限性回肠炎：一种病理与临床实体。1932年。
Mt Sinai J Med. 2000 May;67(3):263-8.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验